Reports, Forms, and Record Keeping Requirements, 42225-42226 [2017-18827]
Download as PDF
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Federal Register / Vol. 82, No. 171 / Wednesday, September 6, 2017 / Notices
John T. Murchison, Jr. (TN)
Axel J.M. Murphy (MN)
Charles M. Naylis (PA)
Craig J. Nelson (IL)
Richard A. Nigro (NJ)
Thomas S. O’Brien (TX)
Paul T. Ozbun (OK)
Modesto F. Pedote (NY)
David M. Pomeroy (IA)
Matthew C. Preston (KY)
Anthony A. Rachuy (MN)
Dwight B. Richardson (OK)
James C. Rocco (NJ)
Patrick J. Severance (NY)
Billy L. Wagner (IL)
Steven L. Wear (ND)
James T. Young (MI)
David J. Zelhart (IL)
The drivers were included in docket
number FMCSA–2015–0061. Their
exemptions are applicable as of July 23,
2017, and will expire on July 23, 2019.
As of July 26, 2017, and in accordance
with 49 U.S.C. 31136(e) and 31315, the
following ten individuals have satisfied
the renewal conditions for obtaining an
exemption from the rule prohibiting
drivers with ITDM from driving CMVs
in interstate commerce (76 FR 32012; 76
FR 44650):
Teddy L. Beach (ND)
Franklin L. Bell (NE)
Jeffrey F. Borelli (OH)
Dale E. Burke (WA)
Boyd L. Croshaw (UT)
Derek Haagensen (MN)
Todd J. Smith (NY)
Andrew C. Winsberg (WA)
Nathan E. Woodin (IL)
Vicky A. Yernesek (WI)
The drivers were included in docket
number FMCSA–2011–0143. Their
exemptions are applicable as of July 26,
2017, and will expire on July 26, 2019.
As of July 28, 2017, and in accordance
with 49 U.S.C. 31136(e) and 31315, the
following 34 individuals have satisfied
the renewal conditions for obtaining an
exemption from the rule prohibiting
drivers with ITDM from driving CMVs
in interstate commerce (73 FR 33144; 73
FR 43817; 74 FR 26467; 74 FR 37293):
Jeromy B. Birchard (MN)
Bradley M. Brown (TX)
Robert F. Browne III (NH)
William M. Camp (GA)
Robert F. Carter (IN)
Scott A. Cary (NC)
Eugene W. Clark, Jr. (WI)
William D. Cornwell III (OH)
Adam F. Demeter (NY)
Brian P. Dionne (NH)
Richard C. Dunn (CT)
Donald K. Ennis (NC)
Larry A. Fritz (PA)
Jerret L. Gerber (WI)
Alan L. Johnson (WA)
Richard B. Lorimer (MO)
VerDate Sep<11>2014
17:37 Sep 05, 2017
Jkt 241001
Lester J. Manis (MD)
Troy A. Martinson (WI)
Richard L. Miller (OH)
Jerome A. Mjolsness (MN)
Richard Murphy (NH)
Edward F. Murray (NY)
Nicholas W. Pomnitz (NJ)
Clayton M. Reynolds (WA)
Brandon M. Ross (ND)
Jeffrey S. SaintVincent (CA)
Patrick D. Schiller (MI)
Bruce D. Schmoyer (PA)
Joseph E. Sobiech (WI)
James L. Swedenburg (MN)
Gary A. Sweeney (NY)
Lawrence M. Tanner (NV)
Robert D. Tarkington (AK)
Joshua C. Webb (AR)
The drivers were included in one of
the following docket numbers: FMCSA–
2008–0137; FMCSA–2009–0122. Their
exemptions are applicable as of July 28,
2017, and will expire on July 28, 2019.
In accordance with 49 U.S.C. 31315,
each exemption will be valid for two
years from the effective date unless
revoked earlier by FMCSA. The
exemption will be revoked if the
following occurs: (1) The person fails to
comply with the terms and conditions
of the exemption; (2) the exemption has
resulted in a lower level of safety than
was maintained prior to being granted;
or (3) continuation of the exemption
would not be consistent with the goals
and objectives of 49 U.S.C. 31136 and
31315.
Issued on: August 25, 2017.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2017–18826 Filed 9–5–17; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
National Highway Traffic Safety
Administration
[U.S. DOT Docket No. NHTSA–2017–0057]
Reports, Forms, and Record Keeping
Requirements
National Highway Traffic
Safety Administration, DOT.
ACTION: Notice.
AGENCY:
In compliance with the
Paperwork Reduction Act of 1995, this
notice announces that the Information
Collection Request (ICR) abstracted
below will be submitted to the Office of
Management and Budget (OMB) for
review. The ICR describes the nature of
the information collection and its
expected burden.
DATES: Comments must be received on
or before November 6, 2017.
SUMMARY:
PO 00000
Frm 00170
Fmt 4703
Sfmt 4703
42225
You may submit comments
identified by DOT Docket ID Number
NHTSA–2017–0057 using any of the
following methods:
Electronic submissions: Go to https://
www.regulations.gov and follow the online instructions for submitting
comments.
Mail, Hand Delivery, or Courier: U.S.
Department of Transportation, 1200
New Jersey Avenue SE., Docket
Management Facility, M–30, Room
W12–140, Washington, DC 20590.
Docket hours are 9 a.m. to 5 p.m.,
Monday through Friday, except Federal
holidays; phone 202–647–5527.
FOR FURTHER INFORMATION CONTACT: Ms.
Amy Berning, Contracting Officer’s
Representative, Office of Behavioral
Safety Research, National Highway
Traffic Safety Administration, 1200 New
Jersey Avenue SE., Washington, DC
20590. Ms. Berning’s phone number is
202–366–5587 and the email address is
amy.berning@dot.gov.
SUPPLEMENTARY INFORMATION:
OMB Control Number: None.
Title: Drug Use by Drivers Arrested for
Driving Under the Influence or Driving
While Under the Influence of Drugs
Form Number: This collection of
information uses no standard forms.
Type of Request: Regular.
Respondents—Under this proposed
effort, NHTSA will collect data from
approximately 1,000 drivers/
participants.
Estimated time per Participant—
NHTSA estimates that participants will
spend an average of 15 minutes to
complete the survey and provide the
oral fluid specimen. The respondents
would not incur any reporting cost or
record keeping burden from the data
collection.
Total Estimated Annual Burden
Hours: 250 hours per year.
Frequency of Collection: Each
participant will provide one oral fluid
sample and respond to the survey
questions only once during the study
period.
Summary of Collection of
Information: This study will estimate
the prevalence of drugs in drivers
arrested for impaired driving. The goal
is to better understand the frequency of
alcohol, prescription, over-the-counter,
and illicit drugs, in impaired driving
arrests.
A minimum of 1,000 drivers arrested
for impaired driving, who consent to
voluntarily participate, will provide an
oral fluid sample and respond to
interview questions. The oral fluid
sample provides information on the
participant’s use of 50 or more drug(s).
Trained researchers will ask
ADDRESSES:
E:\FR\FM\06SEN1.SGM
06SEN1
asabaliauskas on DSKBBXCHB2PROD with NOTICES
42226
Federal Register / Vol. 82, No. 171 / Wednesday, September 6, 2017 / Notices
participants questions regarding
demographics, driving, alcohol, and
drug use.
Data collection would take place over
a six month period at two to three sites
across the country. The research team
will coordinate with the local police
departments and officials at these sites.
There will be a private room at each
police department’s booking facility for
this study’s use.
A police officer will briefly inform the
driver/potential participant of the
opportunity to participate in a research
study sponsored by NHTSA. If the
driver is interested, a researcher will
provide full information about the
study. If the driver is not interested, no
information will be collected on that
person. The researcher will highlight
that participation is voluntary, the oral
fluid and survey responses will be
anonymous, and the participant may
stop the study at any time. The results
of the drug test and questionnaire will
not be provided to anyone outside of the
research team (including to the
participant), and participation in the
study will not be used to help or hurt
the individual in any related legal
proceedings. All participants must be 18
years of age or older to participate.
To provide an oral fluid sample, a
participant simply places a cotton swab
in their mouth for approximately 5
minutes. The specimen will be sent to
an independent laboratory for analyses.
The participant will also be provided a
self-report survey on alcohol and drug
use, perceptions of impaired driving,
and driving behaviors. This survey will
take approximately 10 minutes and will
be conducted via an electronic tablet or,
if needed, a paper copy will be
available. All data will be housed on a
secure data collection and management
site. No identifying participant
information will be collected or used in
the study. Drug test results will only be
associated with survey responses using
a project subject code.
Description of the Need for the
Information and Proposed Use of the
Information: The purpose of this study
is to examine the drug presence and
drug use characteristics of drivers
arrested for impaired driving. While
there is extensive research on alcoholimpaired driving, significantly less is
known about the prevalence and risk
factors of over-the-counter, prescription,
and illegal drug-positive driving. A
significant reason for this lack of
information is that impaired drivers
with alcohol in their system are rarely
tested for other drugs and, when tested,
are only tested for a few drugs. To
address this knowledge gap, this study
will obtain a biological specimen from
VerDate Sep<11>2014
17:37 Sep 05, 2017
Jkt 241001
the drivers, to directly learn about drug
use, along with collecting self-report
data.
The data will be used to better
understand the prevalence of a variety
of drugs in impaired drivers and better
understand risk factors for drugimpaired driving.
Authority: 44 U.S.C. Section 3506(c)(2)(A).
Issued in Washington, DC.
Jeff Michael,
Associate Administrator, Research and
Program Development.
[FR Doc. 2017–18827 Filed 9–5–17; 8:45 am]
BILLING CODE 4910–59–P
DEPARTMENT OF THE TREASURY
Internal Revenue Service
Proposed Collection; Comment
Request for Sale of Residence From
Qualified Personal Residence Trust
(T.D. 8743)
Internal Revenue Service (IRS),
Treasury.
ACTION: The Internal Revenue Service
(IRS), as part of its continuing effort to
reduce paperwork and respondent
burden, invites the general public and
other Federal agencies to take this
opportunity to comment on proposed
and/or continuing information
collections, as required by the
Paperwork Reduction Act of 1995. The
IRS is soliciting comments concerning
information collection requirements
related to Sale of Residence From
Qualified Personal Residence Trust.
AGENCY:
Written comments should be
received on or before November 6, 2017
to be assured of consideration.
ADDRESSES: Direct all written comments
to L. Brimmer, Internal Revenue
Service, Room 6526, 1111 Constitution
Avenue NW., Washington, DC 20224.
Requests for additional information or
copies of the regulation should be
directed to Taquesha Cain, Room 6526,
1111 Constitution Avenue NW.,
Washington, DC 20224, or through the
internet at Taquesha.R.Cain@irs.gov.
SUPPLEMENTARY INFORMATION: Title: Sale
of Residence From Qualified Personal
Residence Trust.
OMB Number: 1545–1485.
Regulation Project Number: T.D. 8743
Abstract: Internal Revenue Code
section 2702(a)(3) provides special
favorable valuation rules for valuing the
gift of a personal residence trust.
Regulation section 25.2702–5(a)(2)
provides that if the trust fails to comply
with the requirements contained in the
regulations, the trust will be treated as
DATES:
PO 00000
Frm 00171
Fmt 4703
Sfmt 9990
complying if a statement is attached to
the gift tax return reporting the gift
stating that a proceeding has been
commenced to reform the instrument to
comply with the requirements of the
regulations.
Current Actions: There is no change
in the paperwork burden previously
approved by OMB.
Type of Review: Extension of a
currently approved collection.
Affected Public: Individuals or
households.
Estimated Number of Respondents:
200.
Estimated Time per Respondent: 3
hour, 7 minutes.
Estimated Total Annual Burden
Hours: 625.
The following paragraph applies to all
of the collections of information covered
by this notice:
An agency may not conduct or
sponsor, and a person is not required to
respond to, a collection of information
unless the collection of information
displays a valid OMB control number.
Books or records relating to a collection
of information must be retained as long
as their contents may become material
in the administration of any internal
revenue law. Generally, tax returns and
tax return information are confidential,
as required by 26 U.S.C. 6103.
Request for comments: Comments
submitted in response to this notice will
be summarized and/or included in the
request for OMB approval. All
comments will become a matter of
public record. Comments are invited on:
(a) Whether the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the collection of
information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; (d) ways to
minimize the burden of the collection of
information on respondents, including
through the use of automated collection
techniques or other forms of information
technology; and (e) estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information.
Approved: August 29, 2017.
L. Brimmer,
Senior Tax Analyst.
[FR Doc. 2017–18839 Filed 9–5–17; 8:45 am]
BILLING CODE 4830–01–P
E:\FR\FM\06SEN1.SGM
06SEN1
Agencies
[Federal Register Volume 82, Number 171 (Wednesday, September 6, 2017)]
[Notices]
[Pages 42225-42226]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-18827]
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
National Highway Traffic Safety Administration
[U.S. DOT Docket No. NHTSA-2017-0057]
Reports, Forms, and Record Keeping Requirements
AGENCY: National Highway Traffic Safety Administration, DOT.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with the Paperwork Reduction Act of 1995, this
notice announces that the Information Collection Request (ICR)
abstracted below will be submitted to the Office of Management and
Budget (OMB) for review. The ICR describes the nature of the
information collection and its expected burden.
DATES: Comments must be received on or before November 6, 2017.
ADDRESSES: You may submit comments identified by DOT Docket ID Number
NHTSA-2017-0057 using any of the following methods:
Electronic submissions: Go to https://www.regulations.gov and follow
the on-line instructions for submitting comments.
Mail, Hand Delivery, or Courier: U.S. Department of Transportation,
1200 New Jersey Avenue SE., Docket Management Facility, M-30, Room W12-
140, Washington, DC 20590.
Docket hours are 9 a.m. to 5 p.m., Monday through Friday, except
Federal holidays; phone 202-647-5527.
FOR FURTHER INFORMATION CONTACT: Ms. Amy Berning, Contracting Officer's
Representative, Office of Behavioral Safety Research, National Highway
Traffic Safety Administration, 1200 New Jersey Avenue SE., Washington,
DC 20590. Ms. Berning's phone number is 202-366-5587 and the email
address is amy.berning@dot.gov.
SUPPLEMENTARY INFORMATION:
OMB Control Number: None.
Title: Drug Use by Drivers Arrested for Driving Under the Influence
or Driving While Under the Influence of Drugs
Form Number: This collection of information uses no standard forms.
Type of Request: Regular.
Respondents--Under this proposed effort, NHTSA will collect data
from approximately 1,000 drivers/participants.
Estimated time per Participant--NHTSA estimates that participants
will spend an average of 15 minutes to complete the survey and provide
the oral fluid specimen. The respondents would not incur any reporting
cost or record keeping burden from the data collection.
Total Estimated Annual Burden Hours: 250 hours per year.
Frequency of Collection: Each participant will provide one oral
fluid sample and respond to the survey questions only once during the
study period.
Summary of Collection of Information: This study will estimate the
prevalence of drugs in drivers arrested for impaired driving. The goal
is to better understand the frequency of alcohol, prescription, over-
the-counter, and illicit drugs, in impaired driving arrests.
A minimum of 1,000 drivers arrested for impaired driving, who
consent to voluntarily participate, will provide an oral fluid sample
and respond to interview questions. The oral fluid sample provides
information on the participant's use of 50 or more drug(s). Trained
researchers will ask
[[Page 42226]]
participants questions regarding demographics, driving, alcohol, and
drug use.
Data collection would take place over a six month period at two to
three sites across the country. The research team will coordinate with
the local police departments and officials at these sites. There will
be a private room at each police department's booking facility for this
study's use.
A police officer will briefly inform the driver/potential
participant of the opportunity to participate in a research study
sponsored by NHTSA. If the driver is interested, a researcher will
provide full information about the study. If the driver is not
interested, no information will be collected on that person. The
researcher will highlight that participation is voluntary, the oral
fluid and survey responses will be anonymous, and the participant may
stop the study at any time. The results of the drug test and
questionnaire will not be provided to anyone outside of the research
team (including to the participant), and participation in the study
will not be used to help or hurt the individual in any related legal
proceedings. All participants must be 18 years of age or older to
participate.
To provide an oral fluid sample, a participant simply places a
cotton swab in their mouth for approximately 5 minutes. The specimen
will be sent to an independent laboratory for analyses. The participant
will also be provided a self-report survey on alcohol and drug use,
perceptions of impaired driving, and driving behaviors. This survey
will take approximately 10 minutes and will be conducted via an
electronic tablet or, if needed, a paper copy will be available. All
data will be housed on a secure data collection and management site. No
identifying participant information will be collected or used in the
study. Drug test results will only be associated with survey responses
using a project subject code.
Description of the Need for the Information and Proposed Use of the
Information: The purpose of this study is to examine the drug presence
and drug use characteristics of drivers arrested for impaired driving.
While there is extensive research on alcohol-impaired driving,
significantly less is known about the prevalence and risk factors of
over-the-counter, prescription, and illegal drug-positive driving. A
significant reason for this lack of information is that impaired
drivers with alcohol in their system are rarely tested for other drugs
and, when tested, are only tested for a few drugs. To address this
knowledge gap, this study will obtain a biological specimen from the
drivers, to directly learn about drug use, along with collecting self-
report data.
The data will be used to better understand the prevalence of a
variety of drugs in impaired drivers and better understand risk factors
for drug-impaired driving.
Authority: 44 U.S.C. Section 3506(c)(2)(A).
Issued in Washington, DC.
Jeff Michael,
Associate Administrator, Research and Program Development.
[FR Doc. 2017-18827 Filed 9-5-17; 8:45 am]
BILLING CODE 4910-59-P